Free Trial
NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

Teleflex logo
$178.16 +3.37 (+1.93%)
(As of 12/20/2024 05:31 PM ET)

About Teleflex Stock (NYSE:TFX)

Key Stats

Today's Range
$174.96
$179.09
50-Day Range
$172.66
$239.94
52-Week Range
$171.69
$256.85
Volume
1.34 million shs
Average Volume
389,839 shs
Market Capitalization
$8.27 billion
P/E Ratio
35.42
Dividend Yield
0.76%
Price Target
$252.50
Consensus Rating
Moderate Buy

Company Overview

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
98th Percentile Overall Score

TFX MarketRank™: 

Teleflex scored higher than 98% of companies evaluated by MarketBeat, and ranked 33rd out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Teleflex has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Teleflex has only been the subject of 4 research reports in the past 90 days.

  • Read more about Teleflex's stock forecast and price target.
  • Earnings Growth

    Earnings for Teleflex are expected to grow by 8.94% in the coming year, from $13.98 to $15.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Teleflex is 35.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.73.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Teleflex is 35.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.11.

  • Price to Earnings Growth Ratio

    Teleflex has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Teleflex has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.07% of the float of Teleflex has been sold short.
  • Short Interest Ratio / Days to Cover

    Teleflex has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teleflex has recently decreased by 26.87%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Teleflex has a dividend yield of 0.78%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Teleflex does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Teleflex is 27.04%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Teleflex will have a dividend payout ratio of 8.93% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

  • Read more about Teleflex's dividend.
  • Percentage of Shares Shorted

    1.07% of the float of Teleflex has been sold short.
  • Short Interest Ratio / Days to Cover

    Teleflex has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teleflex has recently decreased by 26.87%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Teleflex has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Teleflex this week, compared to 8 articles on an average week.
  • Search Interest

    3 people have searched for TFX on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Teleflex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.43% of the stock of Teleflex is held by insiders.

  • Percentage Held by Institutions

    95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Teleflex's insider trading history.
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

How to piss off your liberal friends… and profit from it
Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.
Needham Reaffirms Their Hold Rating on Teleflex (TFX)
Teleflex Incorporated: Compelling Only On One Metric
See More Headlines

TFX Stock Analysis - Frequently Asked Questions

Teleflex's stock was trading at $249.34 at the beginning of 2024. Since then, TFX shares have decreased by 28.5% and is now trading at $178.16.
View the best growth stocks for 2024 here
.

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, October, 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. Teleflex's revenue for the quarter was up 2.4% on a year-over-year basis.
Read the conference call transcript
.

Teleflex's top institutional investors include Janus Henderson Group PLC (11.58%), State Street Corp (4.43%), Geode Capital Management LLC (2.43%) and Massachusetts Financial Services Co. MA (0.92%). Insiders that own company stock include Liam Kelly, Thomas E Powell, Cameron P Hicks and Stuart A Randle.
View institutional ownership trends
.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teleflex investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Home Depot (HD), Advanced Micro Devices (AMD) and Netflix (NFLX).

Company Calendar

Last Earnings
10/31/2024
Ex-Dividend for 12/16 Dividend
11/15/2024
Dividend Payable
12/16/2024
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
87936910
Employees
14,500
Year Founded
1943

Price Target and Rating

Average Stock Price Target
$252.50
High Stock Price Target
$290.00
Low Stock Price Target
$200.00
Potential Upside/Downside
+41.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$356.33 million
Pretax Margin
8.67%

Debt

Sales & Book Value

Annual Sales
$3.03 billion
Cash Flow
$18.62 per share
Book Value
$94.49 per share

Miscellaneous

Free Float
45,780,000
Market Cap
$8.27 billion
Optionable
Optionable
Beta
1.16

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:TFX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners